Dermato-Oncologists are specialized healthcare professionals who focus on diagnosing, treating, and managing skin cancers, such as melanoma, basal cell carcinoma, squamous cell carcinoma, and other rare skin malignancies. These specialists possess expertise in both dermatology and oncology, allowing them to detect early signs of skin cancer and provide comprehensive treatment. They use advanced diagnostic tools, including dermoscopy, skin biopsies, and imaging techniques, to accurately identify skin cancers and develop personalized treatment plans, which may involve surgery, Mohs micrographic surgery, immunotherapy, or targeted therapies.
Dermato-oncologists play an essential role in prevention and patient education. They guide patients on proper sun protection, the importance of regular skin checks, and early detection methods, especially for high-risk individuals. Dermato-oncologists collaborate closely with other specialists, such as oncologists, dermatopathologists, and surgeons, to offer multidisciplinary care for patients. They are also actively involved in clinical research, working to develop more effective treatments and improve early detection methods. Through their expertise, dermato-oncologists not only treat skin cancers but also contribute to long-term skin health and cancer prevention. Their role extends to guiding patients through their cancer journey, providing both medical and emotional support. With their commitment to early detection, dermato-oncologists significantly improve the prognosis and quality of life for patients.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China